278 related articles for article (PubMed ID: 34115827)
21. Genetic and epigenetic insights into cutaneous T-cell lymphoma.
Tensen CP; Quint KD; Vermeer MH
Blood; 2022 Jan; 139(1):15-33. PubMed ID: 34570882
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract][Full Text] [Related]
23. Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides.
Bastidas Torres AN; Cats D; Mei H; Szuhai K; Willemze R; Vermeer MH; Tensen CP
Genes Chromosomes Cancer; 2018 Dec; 57(12):653-664. PubMed ID: 30144205
[TBL] [Abstract][Full Text] [Related]
24. Biological insights into the pathogenesis of cutaneous T-cell lymphomas (CTCL).
Whittaker S
Semin Oncol; 2006 Feb; 33(1 Suppl 3):S3-6. PubMed ID: 16516668
[TBL] [Abstract][Full Text] [Related]
25. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
26. New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications.
Luna DE; Shinohara MM
Curr Hematol Malig Rep; 2023 Jun; 18(3):83-88. PubMed ID: 37017872
[TBL] [Abstract][Full Text] [Related]
27. Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas.
Dommann SN; Dommann-Scherrer CC; Dours-Zimmermann MT; Zimmermann DR; Kural-Serbes B; Burg G
Arch Dermatol Res; 1996 Apr; 288(4):163-7. PubMed ID: 8967786
[TBL] [Abstract][Full Text] [Related]
28. Single-Cell Heterogeneity of Cutaneous T-Cell Lymphomas Revealed Using RNA-Seq Technologies.
Rassek K; Iżykowska K
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751918
[TBL] [Abstract][Full Text] [Related]
29. Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression.
Borcherding N; Voigt AP; Liu V; Link BK; Zhang W; Jabbari A
Clin Cancer Res; 2019 May; 25(10):2996-3005. PubMed ID: 30718356
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma.
Licht P; Mailänder V
Cells; 2022 Jan; 11(3):. PubMed ID: 35159138
[TBL] [Abstract][Full Text] [Related]
31. Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures.
Herrera A; Cheng A; Mimitou EP; Seffens A; George D; Bar-Natan M; Heguy A; Ruggles KV; Scher JU; Hymes K; Latkowski JA; Ødum N; Kadin ME; Ouyang Z; Geskin LJ; Smibert P; Buus TB; Koralov SB
Blood; 2021 Oct; 138(16):1456-1464. PubMed ID: 34232982
[TBL] [Abstract][Full Text] [Related]
32. Independent Loss of Methylthioadenosine Phosphorylase (MTAP) in Primary Cutaneous T-Cell Lymphoma.
Woollard WJ; Kalaivani NP; Jones CL; Roper C; Tung L; Lee JJ; Thomas BR; Tosi I; Ferreira S; Beyers CZ; McKenzie RCT; Butler RM; Lorenc A; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2016 Jun; 136(6):1238-1246. PubMed ID: 26872600
[TBL] [Abstract][Full Text] [Related]
33. Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.
Horna P; Moscinski LC; Sokol L; Shao H
Cytometry B Clin Cytom; 2019 May; 96(3):234-241. PubMed ID: 30328260
[TBL] [Abstract][Full Text] [Related]
34. Expression of Granulysin and FOXP3 in Cutaneous T Cell Lymphoma and Sézary Syndrome.
Shareef MM; Elgarhy LH; Wasfy Rel-S
Asian Pac J Cancer Prev; 2015; 16(13):5359-64. PubMed ID: 26225678
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.
García-Colmenero L; González J; Sandoval J; Guillén Y; Diaz-Lagares A; Andrades E; Iglesias A; Nonell L; Pujol RM; Bigas A; Espinosa L; Gallardo F
Cells; 2020 Dec; 9(12):. PubMed ID: 33333886
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides.
van Kester MS; Borg MK; Zoutman WH; Out-Luiting JJ; Jansen PM; Dreef EJ; Vermeer MH; van Doorn R; Willemze R; Tensen CP
J Invest Dermatol; 2012 Aug; 132(8):2050-9. PubMed ID: 22513784
[TBL] [Abstract][Full Text] [Related]
37. Mycosis fungoides and Sézary syndrome.
Jonak C; Tittes J; Brunner PM; Guenova E
J Dtsch Dermatol Ges; 2021 Sep; 19(9):1307-1334. PubMed ID: 34541796
[TBL] [Abstract][Full Text] [Related]
38. Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas.
Gaydosik AM; Stonesifer CJ; Khaleel AE; Geskin LJ; Fuschiotti P
Clin Cancer Res; 2022 Jun; 28(12):2610-2622. PubMed ID: 35421230
[TBL] [Abstract][Full Text] [Related]
39. The Role of Tumor Microenvironment in Mycosis Fungoides and Sézary Syndrome.
Liu Z; Wu X; Hwang ST; Liu J
Ann Dermatol; 2021 Dec; 33(6):487-496. PubMed ID: 34858000
[TBL] [Abstract][Full Text] [Related]
40. Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome.
Kawana Y; Suga H; Kamijo H; Miyagaki T; Sugaya M; Sato S
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
